Recombinant human adenovirus type 5 vector Ebola vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human adenovirus type 5 vector Ebola vaccine, covering 2016-09-01 to 2016-09-01. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine [Phase 2]